Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
0.6470
Dollar change
+0.0470
Percentage change
7.83
%
Index- P/E- EPS (ttm)-0.75 Insider Own52.81% Shs Outstand36.03M Perf Week4.15%
Market Cap24.47M Forward P/E- EPS next Y-0.55 Insider Trans0.00% Shs Float17.85M Perf Month-39.53%
Income-27.39M PEG- EPS next Q-0.18 Inst Own2.91% Short Float0.05% Perf Quarter-57.99%
Sales3.93M P/S6.23 EPS this Y11.43% Inst Trans14.35% Short Ratio0.43 Perf Half Y-42.74%
Book/sh0.23 P/B2.80 EPS next Y11.29% ROA-74.07% Short Interest0.01M Perf Year-70.05%
Cash/sh0.11 P/C6.00 EPS next 5Y- ROE-132.46% 52W Range0.55 - 2.32 Perf YTD-47.18%
Dividend Est.- P/FCF- EPS past 5Y-34.57% ROI-160.98% 52W High-72.11% Beta0.81
Dividend TTM- Quick Ratio0.46 Sales past 5Y-39.43% Gross Margin2.11% 52W Low17.61% ATR (14)0.09
Dividend Ex-Date- Current Ratio0.46 EPS Y/Y TTM-51.03% Oper. Margin-709.27% RSI (14)33.91 Volatility9.94% 14.52%
Employees45 Debt/Eq0.95 Sales Y/Y TTM7.68% Profit Margin-697.59% Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.95 EPS Q/Q-41.97% Payout- Rel Volume0.31 Prev Close0.60
Sales Surprise- EPS Surprise- Sales Q/Q2590.14% EarningsMay 15 AMC Avg Volume21.63K Price0.65
SMA20-17.26% SMA50-35.32% SMA200-51.38% Trades Volume6,601 Change7.83%
May-15-24 09:53PM
04:39PM
Apr-01-24 10:53PM
04:10PM
Nov-14-23 07:00AM
07:30AM Loading…
Nov-08-23 07:30AM
Nov-01-23 07:30AM
Sep-16-23 11:00AM
Sep-14-23 01:27PM
Sep-09-23 01:00PM
Sep-06-23 07:30AM
Aug-11-23 07:01AM
07:00AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
06:28AM Loading…
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 07:10AM
06:53AM Loading…
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-07-23 06:28AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-22-23 07:05AM
Jun-21-23 07:05AM
Jun-20-23 06:35AM
Jun-15-23 06:38AM
Jun-14-23 07:30AM
06:39AM
Jun-13-23 06:37AM
Jun-12-23 06:47AM
Jun-09-23 06:34AM
May-10-23 06:13AM
May-09-23 07:15AM
Apr-27-23 07:40AM
Apr-13-23 07:15AM
Apr-03-23 08:13AM
Mar-28-23 04:25PM
Feb-13-23 05:21AM
Jan-03-23 07:50AM
Dec-08-22 07:55AM
Dec-07-22 07:30AM
Nov-08-22 07:00AM
Nov-07-22 04:45PM
Aug-28-22 08:06AM
Aug-12-22 07:00AM
Aug-03-22 07:15AM
Jul-27-22 07:56AM
Jun-27-22 06:27AM
May-23-22 07:30AM
May-13-22 07:15AM
May-05-22 07:30AM
Apr-19-22 07:33AM
Apr-02-22 01:10PM
Mar-28-22 07:00AM
Mar-24-22 08:00AM
Jan-24-22 09:22AM
07:00AM
Jan-20-22 09:24AM
08:00AM
Jan-19-22 08:00AM
Jan-18-22 06:27AM
Jan-06-22 07:33AM
Dec-13-21 07:31AM
Nov-12-21 07:00AM
Oct-28-21 02:45PM
12:13PM
12:06PM
11:28AM
10:44AM
07:00AM
06:16AM
Oct-27-21 07:00AM
Oct-20-21 07:30AM
Aug-31-21 09:08AM
Aug-25-21 09:14AM
Aug-24-21 07:32AM
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rhode PeterSee RemarksDec 11 '23Option Exercise0.1414,0001,96077,500Dec 11 04:56 PM
Flowers LeeSVP of Business DevelopmentDec 08 '23Option Exercise0.147,5011,050118,809Dec 11 04:56 PM
Rhode PeterSee RemarksNov 17 '23Option Exercise0.1415,0002,10063,500Nov 20 04:55 PM
Byam RebeccaChief Financial OfficerOct 19 '23Option Exercise0.1447,2496,615621,195Oct 23 04:44 PM
Wong Hing CChief Executive OfficerSep 14 '23Buy2.081,8003,74115,314,868Sep 18 04:36 PM
Winer Gary MDirectorSep 14 '23Buy2.051,0412,13917,000Sep 15 06:53 PM
Byam RebeccaChief Financial OfficerSep 13 '23Buy2.105,00010,490573,946Sep 15 06:52 PM
Winer Gary MDirectorSep 13 '23Buy2.055461,11715,959Sep 15 06:53 PM
Byam RebeccaChief Financial OfficerSep 12 '23Buy2.095,00010,442568,946Sep 13 05:33 PM
Winer Gary MDirectorSep 12 '23Buy2.055001,02515,413Sep 12 08:40 PM
Byam RebeccaChief Financial OfficerSep 11 '23Buy2.055,00010,273563,946Sep 13 05:33 PM
Winer Gary MDirectorSep 11 '23Buy2.059920314,913Sep 12 08:40 PM
Byam RebeccaChief Financial OfficerSep 08 '23Buy2.025,00010,111558,946Sep 08 05:25 PM
Winer Gary MDirectorSep 08 '23Buy1.901214,814Sep 12 08:40 PM
Byam RebeccaChief Financial OfficerSep 07 '23Buy1.955,0009,742553,946Sep 08 05:25 PM
Winer Gary MDirectorSep 07 '23Buy1.956312314,813Sep 07 04:48 PM
Byam RebeccaChief Financial OfficerSep 06 '23Buy1.955,0009,749548,946Sep 07 04:47 PM
Winer Gary MDirectorSep 05 '23Buy1.7540070014,750Sep 07 04:48 PM